使用散布式血管内凝血指数进行散布式血管内凝血的诊断和预后评估
Eri Nakano1,2, Hideo Wada3, Akitaka Yamamoto4
1Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
Journal of clinical medicine
|November 13, 2025
概括
使用PT-INR,D-二次数和血小板计数计算的新DIC指数显示,它与诊断散布血管内凝血 (DIC) 和预测患者结果的现有标准具有很高的一致性.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 现有的JMHLW,ISTH和JAAM分布式血管内凝血 (DIC) 的诊断标准复杂,截止值各不相同.
- 需要一种更简单,更快速的诊断方法来对重症患者进行DIC.
研究的目的:
- 评估新型DIC指数 (PT-INR x D-二次数/血小板计数) 对诊断DIC的有用性.
- 评估DIC指数在危急病患者预测结果的能力.
主要方法:
- 一项对1500名危急病患者的回顾性分析.
- 计算和评估DIC指数,PT-INR,D-二次数,血小板计数,以及建立的DIC得分 (JMHLW,ISTH,JAAM).
- 使用接收器操作特征 (ROC) 分析来评估诊断一致性和结果预测.
主要成果:
- 与DIC患者相比,DIC患者的PT-INR,D-dimer和DIC指数显著更高,血小板数量较低.
- 在评估的标准中,JMHLW得分显示了最高的诊断一致性.
- 较高的PT-INR,D-dimer,DIC指数和已确定的DIC得分与不存活有关,而在幸存者中观察到较低的血小板数量.
结论:
- 开发的DIC指数与已建立的DIC诊断标准有很强的一致性.
- DIC指数是诊断DIC和预测重症监护机构患者结果的宝贵工具.
相关概念视频
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
280
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
280
01:29Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
339
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
339
01:13Therapeutic Index
6.5K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.5K
01:20Drug Product Performance: In Vitro–In Vivo Correlation
221
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
221
01:09Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K